The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the - 629C→A cholesteryl ester transfer protein promoter polymorphism: Role of lecithin:cholesterol acyltransferase activity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 1-2, 2008, Pages 10-15

  Borggreve, S E ^a   de Vries, R ^a   Dallinga Thie, G M ^b   Wolffenbuttel, B H R ^a   Groen, A K ^b   van Tol, A ^a,c   Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cellular cholesterol efflux; Cholesteryl ester transfer; Cholesteryl ester transfer protein; Cholesteryl ester transfer protein promoter polymorphism; HDL cholesterol; Lecithin:cholesterol acyltransferase; Reverse cholesterol transport; Triglycerides

Indexed keywords

CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE;

ADULT; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FIBROBLAST; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

ADENINE; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CYTOSINE; FIBROBLASTS; HUMANS; MALE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PLASMA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 39049085618     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.10.010     Document Type: Article

References (49)

1. Tall A.R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86 (1990) 379-384
2. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36 (1995) 211-228
3. Barter P.J., and Rye K.A. Cholesteryl ester transfer protein, high density lipoprotein and arterial disease. Curr. Opin. Lipidol. 12 (2001) 377-382
4. Fielding C.J., and Havel R.J. Cholesteryl ester transfer protein: friend or foe?. J. Clin. Invest. 97 (1996) 2687-2688
5. Stein O., and Stein Y. Lipid transfer proteins (LTP) and atherosclerosis. Atherosclerosis 178 (2005) 217-230
6. Tall A.R., Yvan-Charvet L., and Wang N. The failure of torcetrapib: was it the molecule or the mechanism?. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 257-260
7. Tall A.R. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34 (1993) 1255-1274
8. Tato F., Vega G.L., Tall A.R., and Grundy S.M. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 112-120
9. Borggreve S.E., De Vries R., and Dullaart R.P.F. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins. Eur. J. Clin. Invest. 33 (2003) 1051-1069
10. Schwartz C.C., VandenBroek J.M., and Cooper P.S. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J. Lipid Res. 45 (2004) 1594-1607
11. Rye K.A., Clay M.A., and Barter P.J. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145 (1999) 227-238
12. Rye K.A., and Barter P.J. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I, Arterioscler. Thromb. Vasc. Biol. 24 (2004) 421-428
13. Von Eckardstein A., Jauhiainen M., Huang Y.D., Metso J., Langer C., Pussinen P., Wu S.L., Ehnholm C., and Assmann G. Phospholipid transfer protein mediated conversion of high density lipoproteins generates b1-HDL. Biochim. Biophys. Acta L, Lipids Lipid Metab. 1301 (1996) 255-262
14. Castro G.R., and Fielding C.J. Early incorporation of cell-derived cholesterol into pre- beta-migrating high-density lipoprotein. Biochemistry 27 (1988) 25-29
15. Yancey P.G., Bortnick A.E., Kellner-Weibel G., De la Llera-Moya M., Phillips M.C., and Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 712-719
16. Francone O.L., Royer L., and Haghpassand M. Increased preb-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. J. Lipid Res. 37 (1996) 1268-1277
17. Dachet C., Poirier O., Cambien F., Chapman J., and Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels. Role of Sp1/Sp3 in transcriptional regulation. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 507-515
18. Boekholdt S.M., and Thompson J.F. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J. Lipid Res. 44 (2003) 1080-1093
19. Boekholdt S.M., Sacks F.M., Jukema J.W., Shepherd J., Freeman D.J., McMahon A.D., Cambien F., Nicaud V., de Grooth G.J., Talmud P.J., Humphries S.E., Miller G.J., Eiriksdottir G., Gudnason V., Kauma H., Kakko S., Savolainen M.J., Arca M., Montali A., Liu S., Lanz H.J., Zwinderman A.H., Kuivenhoven J.A., and Kastelein J.J. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111 (2005) 278-287
20. Borggreve S.E., Hillege H.L., Wolffenbuttel B.H., de Jong P.E., Bakker S.J., van der Steege G., van Tol A., and Dullaart R.P.F. The effect of CETP - 629C→A promoter polymorphism on HDL cholesterol is dependent on serum triglycerides. J. Clin. Endocrinol. Metab. 90 (2005) 4198-4202
21. van Venrooij F.V., Stolk R.P., Banga J.D., Sijmonsma T.P., van Tol A., Erkelens D.W., and Dallinga-Thie G.M. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes. Diabetes Care 26 (2003) 1216-1223
22. Klerkx A.H., Tanck M.W., Kastelein J.J., Molhuizen H.O., Jukema J.W., Zwinderman A.H., and Kuivenhoven J.A. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked - 629C→A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum. Mol. Genet. 12 (2003) 111-123
23. Frisdal E., Klerkx A.H., Le G.W., Tanck M.W., Lagarde J.P., Jukema J.W., Kastelein J.J., Chapman M.J., and Guerin M. Functional interaction between - 629C/A, - 971G/A and - 1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum. Mol. Genet. 14 (2005) 2607-2618
24. Bruce C., Sharp D.S., and Tall A.R. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J. Lipid Res. 39 (1998) 1071-1078
25. Agerholm-Larsen B., Nordestgaard B.G., Steffensen R., Jensen G., and Tybjærg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 101 (2000) 1907-1912
26. Borggreve S.E., Hillege H.L., Wolffenbuttel B.H., de Jong P.E., Zuurman M.W., van der S.G., Van T.A., and Dullaart R.P. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J. Clin. Endocrinol. Metab. 91 (2006) 3382-3388
27. Marschang P., Sandhofer A., Ritsch A., Fiser I., Kvas E., and Patsch J.R. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin. J. Intern. Med. 260 (2006) 151-159
28. Niemeijer-Kanters S.D.J.M., Dallinga-Thie G.M., Ruijter-Heijstek F.C., Algra A., Erkelens D.W., Banga J.D., and Jansen H. Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus. Atherosclerosis 156 (2001) 209-216
29. Dullaart R.P.F., Riemens S.C., Scheek L.M., and van Tol A. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur. J. Clin. Invest. 29 (1999) 663-671
30. Dullaart R.P.F., Sluiter W.J., Dikkeschei L.D., Hoogenberg K., and van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur. J. Clin. Invest. 24 (1994) 188-194
31. Floren C.H., Chen C.H., Franzen J., and Albers J.J. Lecithin: cholesterol acyltransferase in liver disease. Scand. J. Clin. Lab. Invest. 47 (1987) 613-617
32. de Vries R., Kerstens M.N., Sluiter W.J., Groen A.K., van Tol A., and Dullaart R.P.F. Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment. Diabetologia 48 (2005) 1105-1113
33. Hovingh G.K., van Wijland M.J., Brownlie A., Bisoendial R.J., Hayden M.R., Kastelein J.J., and Groen A.K. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia. J. Lipid Res. 44 (2003) 1251-1255
34. Murakami T., Michelagnoli S., Longhi R., Gianfranceschi G., Pazzucconi F., Calabresi L., Sirtori C.R., and Franceschini G. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1819-1828
35. Tall A., Sammett D., and Granot E. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J. Clin. Invest. 77 (1986) 1163-1172
36. de Vries R., Perton F.G., Dallinga-Thie G.M., van Roon A.M., Wolffenbuttel B.H.R., van Tol A., and Dullaart R.P.F. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes 54 (2005) 3554-3559
37. Wang N., Lan D., Chen W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9774-9779
38. Gelissen I.C., Harris M., Rye K.A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan M., Kritharides L., and Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 534-540
39. Denis M., Bissonnette R., Haidar B., Krimbou L., Bouvier M., and Genest J. Expression, regulation, and activity of ABCA1 in human cell lines. Mol. Genet. Metab. 78 (2003) 265-274
40. Boadu E., Choi H.Y., Lee D.W., Waddington E.I., Chan T., Asztalos B., Vance J.E., Chan A., Castro G., and Francis G.A. Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts. J. Biol. Chem. 281 (2006) 37081-37090
41. Duong M., Collins H.L., Jin W., Zanotti I., Favari E., and Rothblat G.H. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 541-547
42. Van Haperen R., van Tol A., Venmeulen P., Jauhiainen M., van Gent T., Van den Berg P., Ehnholm S., Grosveld F., Van der Kamp A., and De Crom R. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1082-1088
43. Barrans A., Collet X., Barbaras R., Jaspard B., Manent J., Vieu C., Chap H., and Perret B. Hepatic lipase induces the formation of pre-b1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J. Biol. Chem. 269 (1994) 11572-11577
44. Alenezi M.Y., Marcil M., Blank D., Sherman M., and Genest Jr. J. Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?. J. Clin. Endocrinol. Metab. 89 (2004) 761-764
45. de Vries R., Groen A.K., Perton F.G., Dallinga-Thie G.M., van Wijland M.J., Dikkeschei L.D., Wolffenbuttel B.H.R., van Tol A., and Dullaart R.P.F. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis (2007) 10.1016/j.atherosclerosis.2006.12.027
46. Asztalos B.F., de la Llera-Moya M., Dallal G.E., Horvath K.V., Schaefer E.J., and Rothblat G.H. Differential effects of HDL subpopulations on cellular ABCA1- and SRB1-mediated cholesterol efflux. J. Lipid Res. (2005) M500187-MJLR200
47. Czarnecka H., and Yokoyama S. Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. J. Biol. Chem. 271 (1996) 2023-2028
48. Matsuura F., Wang N., Chen W., Jiang X.C., and Tall A.R. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J. Clin. Invest. 116 (2006) 1435-1442
49. Zhang Z., Yamashita S., Hirano K., Nakagawa-Toyama Y., Matsuyama A., Nishida M., Sakai N., Fukasawa M., Arai H., Miyagawa J., and Matsuzawa Y. Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport. Atherosclerosis 159 (2001) 67-75